tiprankstipranks
Advertisement
Advertisement
Scancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
PremiumCompany AnnouncementsScancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
4M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
Premium
Company Announcements
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
5M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
Premium
Company Announcements
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
6M ago
Scancell Holdings: Strategic Share Acquisition by Vulpes Testudo Fund
PremiumCompany AnnouncementsScancell Holdings: Strategic Share Acquisition by Vulpes Testudo Fund
8M ago
Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
Premium
Company Announcements
Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges
8M ago
Scancell Holdings Reports Positive Trial Results and Strategic Developments
Premium
Company Announcements
Scancell Holdings Reports Positive Trial Results and Strategic Developments
8M ago
Scancell Holdings Announces Share Option Exercise and Increased Voting Shares
PremiumCompany AnnouncementsScancell Holdings Announces Share Option Exercise and Increased Voting Shares
10M ago
Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
Premium
Company Announcements
Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study
11M ago
Scancell Holdings Sees Increased Investment from Vulpes Testudo Fund
Premium
Company Announcements
Scancell Holdings Sees Increased Investment from Vulpes Testudo Fund
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100